Stay updated on Cabozantinib vs Everolimus in Metastatic Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib vs Everolimus in Metastatic Renal Cell Carcinoma Clinical Trial page.

Latest updates to the Cabozantinib vs Everolimus in Metastatic Renal Cell Carcinoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe revision label on the page was updated from v3.6.5 to v3.6.6, reflecting a version update to the page's underlying documentation or software. This indicates the content has been refreshed at the system level rather than adding new study information.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page now displays a new revision label, v3.6.5, replacing the previous v3.6.4 to reflect a small backend or build update.SummaryDifference0.0%

- Check47 days agoChange DetectedRevision: v3.6.4 has been added, replacing the previous Revision: v3.6.3. This reflects a minor update to the page version with no changes to the study details.SummaryDifference0.0%

- Check69 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, signaling a small update to the page's software or documentation.SummaryDifference0.0%

- Check77 days agoChange DetectedThe page displays an updated revision tag, changing from v3.6.0 to v3.6.2, indicating an internal update to the page.SummaryDifference0.0%

- Check91 days agoChange DetectedNew help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment header formatting was updated, replacing the old Intervention / Treatment and noting Revision: v3.5.5 with Revision: v3.6.0. A recruitment status update now states No longer looking for participants, indicating the study is no longer enrolling.SummaryDifference0.2%

Stay in the know with updates to Cabozantinib vs Everolimus in Metastatic Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib vs Everolimus in Metastatic Renal Cell Carcinoma Clinical Trial page.